Conference Coverage (ICAAC)

Primary HIV Infection + HAART: Better Than Vaccine?

Published in Vaccine Weekly, October 12th, 1998

Patients who receive highly active antiretroviral therapy (HAART) during primary HIV infection may never get AIDS - even if they stop taking the drugs.

And with some 44,000 new HIV infections expected in the U.S. in the coming year, a major effort should be made to identify and treat such patients, argued Bruce D. Walker of Harvard University and Massachusetts General Hospital, Boston.

"HIV eradication may not be required," Walker said. "Clearly in some individuals the immune system can control the virus."

Walker spoke during the AIDS plenary session that has become traditional for the American Society for Microbiology's 38th...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1998-10-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry